C07D 239/26
With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to
Official title: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
C07D239/26 (With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to) appears on 1,639 US grants and 1,386 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,639
- Published applications
- 1,386
- Assignees
- 671
- Inventors
- 4,895
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 12 | 0 |
| 1977 | 6 | 0 |
| 1978 | 7 | 0 |
| 1979 | 8 | 0 |
| 1980 | 4 | 0 |
| 1981 | 4 | 0 |
| 1982 | 8 | 0 |
| 1983 | 5 | 0 |
| 1984 | 9 | 0 |
| 1985 | 20 | 0 |
| 1986 | 11 | 0 |
| 1987 | 25 | 0 |
| 1988 | 26 | 0 |
| 1989 | 38 | 0 |
| 1990 | 36 | 0 |
| 1991 | 41 | 0 |
| 1992 | 35 | 0 |
| 1993 | 38 | 0 |
| 1994 | 37 | 0 |
| 1995 | 41 | 0 |
| 1996 | 29 | 0 |
| 1997 | 52 | 0 |
| 1998 | 43 | 0 |
| 1999 | 31 | 0 |
| 2000 | 27 | 0 |
| 2001 | 33 | 3 |
| 2002 | 42 | 33 |
| 2003 | 21 | 43 |
| 2004 | 41 | 54 |
| 2005 | 21 | 40 |
| 2006 | 29 | 46 |
| 2007 | 19 | 42 |
| 2008 | 21 | 34 |
| 2009 | 28 | 48 |
| 2010 | 28 | 57 |
| 2011 | 37 | 50 |
| 2012 | 48 | 38 |
| 2013 | 34 | 45 |
| 2014 | 45 | 63 |
| 2015 | 64 | 68 |
| 2016 | 58 | 98 |
| 2017 | 75 | 101 |
| 2018 | 69 | 62 |
| 2019 | 53 | 67 |
| 2020 | 54 | 69 |
| 2021 | 44 | 62 |
| 2022 | 47 | 62 |
| 2023 | 42 | 75 |
| 2024 | 35 | 50 |
| 2025 | 40 | 46 |
| 2026 | 18 | 30 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Organic compound and an organic electroluminescent device using the same7 Jul 2026US 12,673,923 B2Solus Advanced Materials Co., Ltd.
- Valiolamine derivatives as glucosidase inhibitors7 Jul 2026US 12,673,924 B2Emergent Product Development Gaithersburg Inc.
- Chemical compounds and uses thereof23 Jun 2026US 12,662,451 B2Glaxosmithkline Intellectual Property (No. 4) Ltd.
- Organometallic compound and light-emitting device including the same9 Jun 2026US 12,649,756 B2Samsung Display Co., Ltd.
- An organic compound and an organic electroluminescent device using the same1 Oct 2026US 2026/0297034 A1Solus Advanced Materials Co., Ltd.
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Novel mitofusin inhibitors17 Sep 2026US 2026/0274810 A1Albert Einstein College of Medicine
- Novel compound, and pharmaceutical composition comprising same as active ingredient10 Sep 2026US 2026/0265189 A1Sapiensbio Inc.
- Highly water soluble schiff base prodrugs of benzaldehyde allosteric modulators3 Sep 2026US 2026/0256752 A1Illexcor Holdings, LLC
Most cited
By later US patents
- Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds232US 6,670,645 B2E. I. Du Pont de Nemours and Company · 2003
- Light-emitting element192US 9,604,928 B2Semiconductor Energy Laboratory Co.Ltd. · 2017
- Herbicidal sulfonamides124US 4,127,405 AE. I. Du Pont de Nemours and Company · 1978
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Herbicidal sulfonamides102US 4,169,719 AE. I. Du Pont de Nemours and Company · 1979